- Report
- November 2025
- 367 Pages
Global
From €4360EUR$4,950USD£3,832GBP
- Report
- September 2025
- 564 Pages
Global
From €4360EUR$4,950USD£3,832GBP
- Report
- February 2025
- 454 Pages
Global
From €3170EUR$3,599USD£2,787GBP
€4227EUR$4,799USD£3,715GBP
- Report
- November 2025
- 197 Pages
Global
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- November 2025
- 184 Pages
Global
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- August 2025
- 192 Pages
Global
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- August 2025
- 199 Pages
Global
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- May 2025
- 117 Pages
Global
From €4184EUR$4,750USD£3,677GBP
- Report
- April 2025
- 200 Pages
Global
From €3955EUR$4,490USD£3,476GBP
- Report
- February 2025
- 200 Pages
Global
From €3955EUR$4,490USD£3,476GBP
- Report
- December 2025
- 310 Pages
Global
From €5152EUR$5,850USD£4,529GBP
- Report
- December 2025
- 170 Pages
Global
From €5152EUR$5,850USD£4,529GBP
- Report
- December 2025
- 206 Pages
Global
From €5152EUR$5,850USD£4,529GBP
- Report
- April 2023
- 77 Pages
Asia Pacific
From €4360EUR$4,950USD£3,832GBP
- Report
- October 2024
- 231 Pages
Global
From €5240EUR$5,950USD£4,606GBP
- Report
- September 2023
- 110 Pages
Global
From €5240EUR$5,950USD£4,606GBP
- Report
- November 2022
- 117 Pages
Global
From €4360EUR$4,950USD£3,832GBP
- Report
- April 2023
- 115 Pages
Global
From €4184EUR$4,750USD£3,677GBP

The Preclinical Drug market is a segment of the Pharmaceuticals industry that focuses on the development of drugs prior to clinical trials. This includes the research and development of new drugs, as well as the testing of existing drugs for safety and efficacy. Preclinical Drug development involves a range of activities, such as the synthesis of new compounds, the evaluation of their pharmacological properties, and the assessment of their toxicity. The results of these activities are used to determine whether a drug is suitable for clinical trials.
The Preclinical Drug market is highly competitive, with a number of companies offering a range of services. These include contract research organizations (CROs), drug discovery companies, and pharmaceutical companies. Examples of companies in the market include Charles River Laboratories, WuXi AppTec, and Parexel. Show Less Read more